MAM
Clensta appoints Ankit Gaur as the new CGO & Strategy Officer
Mumbai: Home and personal care startup Clensta on Tuesday announced the appointment of Ankit Gaur as their chief growth and strategy officer.
As Clensta gears up to expand its portfolio and offerings, Gaur will be spearheading brand and performance marketing, communication, sales & growth functions for the brand.
With deep expertise in spearheading disruptive innovation, Gaur brings to the table an innate knack for understanding consumer behaviour. In his role, Ankit will be expected to deliver transformational growth in establishing Clensta as the undisputed market leader in home and personal care segment.
An alumnus of the prestigious SP Jain School of Global Management, Gaur comes with an extensive experience of 13 years in the industry, and has worked across different industries and verticals throughout his career. Prior to joining Clensta, Gaur was at the helm of the direct-to-consumer (D2C) business at Livpure. He has also held various senior leadership positions with organisations such as CuroCarte, Ashok Leyland, Wal-Mart India, Big Bazaar India and Wonderchef.
In his previous stint as an entrepreneur, Ankit piloted the launch of his startup, EthnicRoom, an omnichannel ethnic fashion startup, and successfully raised series-A funding for the brand. His expertise as an entrepreneur will be instrumental in strengthening Clensta’s brand positioning across the country.
“We are delighted to have Ankit on board as our chief growth and strategy officer and would like to welcome him to the Clensta family,” said Clensta founder and CEO Puneet Gupta. “Clensta was incorporated in 2016 with a vision to provide affordable and effective cleaning solutions to the world while also ensuring our planet’s commitment by contributing towards reducing pollution and waste. As we complete six years in business and progress towards the next leg of our journey, we are aiming to expand our presence across markets and enhance our product portfolio to include a more comprehensive set of offerings. Ankit, with his extensive experience across different sectors and industry, is a welcome addition to the team and would play a significant role in catapulting the company to newer heights.”
“I am honoured to have been appointed as the chief growth and strategy officer at Clensta,” said Ankit Gaur. “I have been closely following the developments at Clensta and am impressed with what the brand has achieved in such a short span of time. The ecosystem of sustainable consumption and production that Clensta is trying to build is truly commendable and closely mirrors my personal ethos. I am excited about the new role and look forward to establishing Clensta as one of the most sought-after brands in the D2C space.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
